Survey

With the evolution of the medical home and ACO models of healthcare delivery, what do you see as the most essential means by which pharmacy departments can support the success of such models?

a) More active direct patient outreach, education, and consultation.

b) Enhanced provider education and drug info support.

c) Improved ability to deliver more timely and actionable patient-specific drug alerts to PCPs/care managers.

d) Enhanced mechanisms to monitor and improve patient compliance.

e) More advanced analytics to better risk stratify patients for intervention need.

f) More timely and robust reporting to measure pharmacy-specific quality performance metrics.

Digital Edition

Antibacterial use in children associated with increased, dose-dependent CA-MRSA risk

To confirm your e-newsletter subscription, click here.

To ensure future delivery of email newsletters from Formulary, please take a moment to confirm your subscription by clicking here.
Thank you,
Formulary Staff

Once-daily rivaroxaban appears to be as good as dose-adjusted warfarin

US healthcare system among least
cost-effective in reducing mortality

The US healthcare system is one of the least cost-effective in reducing mortality rates; while the United Kingdom is among the most cost-effective, according to a recent study published in the July issue of Journal of the Royal Society of Medicine Short Reports. Read full article.

HRT reanalyses shows favorable
risk-benefit profile with recommended treatment strategies

The risk-benefit ratio is in favor of hormone replacement therapy (HRT) when initiated near menopause, according to new consensus statements issued by The North American Menopause Society, The American Menopause Society, and the International Menopause Society and published in a recent paper in the July issue of Women's Health. Read full article.

FDA approves Adcetris to treat
2 types of lymphoma

FDA has approved brentuximab vedotin (Adcetris, Seattle Genetics) to treat 2 types of lymphoma. Read full article.

FDA-approved cyanide antidote launches

An antidote indicated for the treatment of acute cyanide poisoning judged to be life-threatening has launched. Read full article.